TransMedics Group, Inc. TMDX

TMDX Company Overview

TransMedics Group, Inc. is a medical technology company focused on improving outcomes in organ transplantation by enabling the preservation, assessment, and transportation of donor organs outside the human body. The company operates within the medical devices and healthcare services industries, with a primary emphasis on advanced organ perfusion systems that allow donor organs to remain metabolically active during transport. Its core mission is to increase the utilization of donor organs and expand access to life-saving transplants.

The company’s primary revenue drivers are its Organ Care System (OCS) platforms for heart, lung, and liver transplantation, along with related disposable components and clinical services. TransMedics serves transplant centers, organ procurement organizations (OPOs), and healthcare systems, primarily in the United States and select international markets. Founded in 1998, the company evolved from a device-focused innovator into a vertically integrated transplant logistics and services provider, particularly following the commercialization of its National OCS Program.